These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 37628685)

  • 1. Advancing Epidemiology and Genetic Approaches for the Treatment of Spinal and Bulbar Muscular Atrophy: Focus on Prevalence in the Indigenous Population of Western Canada.
    Wilton-Clark H; Al-Aghbari A; Yang J; Yokota T
    Genes (Basel); 2023 Aug; 14(8):. PubMed ID: 37628685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deterioration of muscle force and contractile characteristics are early pathological events in spinal and bulbar muscular atrophy mice.
    Gray AL; Annan L; Dick JRT; La Spada AR; Hanna MG; Greensmith L; Malik B
    Dis Model Mech; 2020 May; 13(5):. PubMed ID: 32152060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kennedy's disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease.
    Breza M; Koutsis G
    J Neurol; 2019 Mar; 266(3):565-573. PubMed ID: 30006721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From gene to therapy in spinal and bulbar muscular atrophy: Are we there yet?
    Pennuto M; Rinaldi C
    Mol Cell Endocrinol; 2018 Apr; 465():113-121. PubMed ID: 28688959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleic Acid-Based Therapeutic Approach for Spinal and Bulbar Muscular Atrophy and Related Neurological Disorders.
    Hirunagi T; Sahashi K; Meilleur KG; Katsuno M
    Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy (SBMA).
    Banno H; Katsuno M; Suzuki K; Tanaka F; Sobue G
    Cell Tissue Res; 2012 Jul; 349(1):313-20. PubMed ID: 22476656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New routes to therapy for spinal and bulbar muscular atrophy.
    Rocchi A; Pennuto M
    J Mol Neurosci; 2013 Jul; 50(3):514-23. PubMed ID: 23420040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction to the Special Issue on Spinal and Bulbar Muscular Atrophy.
    Pennuto M; Gozes I
    J Mol Neurosci; 2016 Mar; 58(3):313-6. PubMed ID: 26875173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and prevalence of Spinal and bulbar muscular atrophy in South Korea: a nationwide population-based study.
    Park JM; Kang M; Park JS
    J Neurol; 2023 Oct; 270(10):5017-5022. PubMed ID: 37389590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic alterations in spinal and bulbar muscular atrophy.
    Francini-Pesenti F; Vitturi N; Tresso S; Sorarù G
    Rev Neurol (Paris); 2020 Dec; 176(10):780-787. PubMed ID: 32631678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal and bulbar muscular atrophy: From molecular pathogenesis to pharmacological intervention targeting skeletal muscle.
    Marchioretti C; Andreotti R; Zuccaro E; Lieberman AP; Basso M; Pennuto M
    Curr Opin Pharmacol; 2023 Aug; 71():102394. PubMed ID: 37463556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Molecular Therapies for SBMA.
    Rinaldi C; Malik B; Greensmith L
    J Mol Neurosci; 2016 Mar; 58(3):335-42. PubMed ID: 26576772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond motor neurons: expanding the clinical spectrum in Kennedy's disease.
    Manzano R; Sorarú G; Grunseich C; Fratta P; Zuccaro E; Pennuto M; Rinaldi C
    J Neurol Neurosurg Psychiatry; 2018 Aug; 89(8):808-812. PubMed ID: 29353237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal and bulbar muscular atrophy: androgen receptor dysfunction caused by a trinucleotide repeat expansion.
    MacLean HE; Warne GL; Zajac JD
    J Neurol Sci; 1996 Feb; 135(2):149-57. PubMed ID: 8867071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotoxic effects of androgens in spinal and bulbar muscular atrophy.
    Parodi S; Pennuto M
    Front Neuroendocrinol; 2011 Oct; 32(4):416-25. PubMed ID: 21745497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal and bulbar muscular atrophy: pathogenesis and clinical management.
    Grunseich C; Rinaldi C; Fischbeck KH
    Oral Dis; 2014 Jan; 20(1):6-9. PubMed ID: 23656576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patients.
    Grunseich C; Zukosky K; Kats IR; Ghosh L; Harmison GG; Bott LC; Rinaldi C; Chen KL; Chen G; Boehm M; Fischbeck KH
    Neurobiol Dis; 2014 Oct; 70():12-20. PubMed ID: 24925468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of UBA1 as the causative gene of an X-linked non-Kennedy spinal-bulbar muscular atrophy.
    Khani M; Nafissi S; Shamshiri H; Moazzeni H; Taheri H; Sadeghi M; Salehi N; Chitsazian F; Elahi E
    Eur J Neurol; 2022 Dec; 29(12):3556-3563. PubMed ID: 35996994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kennedy disease (X-linked recessive bulbospinal neuronopathy): A comprehensive review from pathophysiology to therapy.
    Querin G; Sorarù G; Pradat PF
    Rev Neurol (Paris); 2017 May; 173(5):326-337. PubMed ID: 28473226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms mediating spinal and bulbar muscular atrophy: investigations into polyglutamine-expanded androgen receptor function and dysfunction.
    Beitel LK; Alvarado C; Mokhtar S; Paliouras M; Trifiro M
    Front Neurol; 2013; 4():53. PubMed ID: 23720649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.